Delivery Order SPE2DB22D1202-SPE2DB25FUPB1
Award Date
1/7/25
Potential Completion Date
1/8/25
Potential Value
$1.5K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Logistics Agency (DLA) has awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a $3,930.60 firm fixed price delivery order contract for the supply of insulin degludec pens (U-200, 3ML). This delivery order is placed under an indefinite delivery contract (IDC) with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle for Amerisourcebergen Drug Corp to deliver...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,733.88 firm fixed price delivery order is for the procurement of Insulin Degludec Pen (U-200) 3ML, which is a specialty medication used for diabetes management.
The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $2,045.19 firm-fixed-price contract is for the supply of insulin degludec pens (U-200, 3 mL) and does not have a set-aside designation.
AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves as a primary vehicle for providing a comprehensive range of...
This federal contract award to Amerisourcebergen Drug Corp is a Delivery Order valued at $1,313.56 for the supply of Insulin Degludec Pen (U-200) 3ML. The contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a major defense agency. This award is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999, that enables the agency to efficiently procure a comprehensive range of pharmaceutical and medical...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of insulin degludec pens (U-200, 3 mL). The contract has a ceiling value of $4,417.19 and a completion date of January 2, 2025. It is a Firm Fixed Price Delivery Order with no set-aside designation, indicating open competition.
Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,190.14 firm fixed-price contract is for the supply of Insulin Degludec Pen (U-200) 3ML, a specialty medication used for diabetes management.
The contract is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical, which...
This federal contract award, with an ID of SPE2DB22D2214|SPE2DB24FS6RA, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Insulin Degludec Pens (U-200) 3ML. The firm-fixed-price delivery order has a ceiling value of $1,502.43 and an ultimate completion date of September 12, 2024. This contract is not designated as a set-aside. AmerisourceBergen holds several Indefinite Delivery Contracts (IDCs) with various...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of insulin degludec pens (U-100, 3 mL). The contract is a delivery order with a firm fixed price of $1,288.93 and a completion date of May 13, 2024. The award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and DLA Troop Support Medical, valued up to $999,999,999.00, which serves as the primary vehicle...
This federal contract award, valued at $2,125.39, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of insulin degludec pens (U-200) 3ML, a specialty medication used for diabetes management. This is a firm fixed-price delivery order contract with an ultimate completion date of October 29, 2024.
Amerisourcebergen holds a significant Indefinite Delivery Contract...
This federal contract award, valued at $1,165.68, was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) Troop Support to Amerisourcebergen Drug Corp's Corporate Office division. The contract is for the delivery of Insulin Degludec Pen (U-200) 3ML, a critical pharmaceutical product. This delivery order award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999 through...